By passing SB 1199, California will join 26 other states, the District of Columbia, and Puerto Rico in protecting consumers purchasing insurance on the private market. This legislation ensures that copay assistance counts toward cost-sharing obligations, preventing patients from facing insurmountable financial barriers to their medications.
Letter to the FTC in support for and recommendations on proposed settlement with Express Scripts
We write to express our support for the proposed settlement with Express Scripts, Inc. and its affiliated entities (collectively “ESI”), to highlight several provisions that will significantly improve affordability and access to medications for patients and propose critical enhancements to further strengthen the order’s protections.
Coverage of preventive services is a legal requirement
Carl Schmid commented on the JAMA Viewpoint piece “Subscription-Based Pricing for Lenacapavir—Learning From Hepatitis C and Cabotegravir,” taking issue with the authors’ dismissal of advocates focus on insurer’s responsibility to follow the law and cover PrEP as a no cost preventive service and offering comments on the hepatitis C subscription model and the need for a comprehensive PrEP program to increase uptake.
HIV+Hep asks NJ Gov. Murphy to sign copay accumulator ban
We strongly support NJ Assembly Bill 5217 which ensures that health insurers accept and count payments made on behalf of patients toward their deductibles and out-of-pocket maximums. We respectfully urge Gov. Phil Murphy to sign Assembly Bill 5217 into law.
Support for NJ S3818/A5217 to ban copay accumulators
We strongly support NJ Senate Bill 3818/Assembly Bill 5217 which ensures that health insurers accept and count payments made on behalf of patients toward their deductibles and out-of-pocket maximums.